Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges (2019 - 2024)
Fennec Pharmaceuticals posted quarterly Amortization of Deferred Charges of -$1.1 million for Q4 2024, down 2069.09% year-on-year from $55000.0 in Q1 2024, and down 459.8% on a QoQ basis from $301000.0 in Q3 2024.
Fennec Pharmaceuticals (FENC) has 6 years of Amortization of Deferred Charges data on file, last reported at -$1.1 million in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges fell 2069.09% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2024 stood at $21000.0 (down 90.5% YoY), and the FY2024 full-year result was $21000.0, down 90.5% from the prior year.
- Amortization of Deferred Charges for Q4 2024 stood at -$1.1 million, down from $301000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $799000.0 in Q2 2024 and bottomed at -$1.1 million in Q4 2024.
- The 5-year median for Amortization of Deferred Charges is $30000.0 (2020), against an average of $46529.4.
- The widest annual swing landed in 2020, when Amortization of Deferred Charges jumped 1988.24%; it then sank 2069.09% in 2024.
- A 5-year view of Amortization of Deferred Charges shows it stood at $355000.0 in 2020, then tumbled by 98.03% to $7000.0 in 2021, then surged by 685.71% to $55000.0 in 2022, then changed by 0.0% to $55000.0 in 2023, then tumbled by 2069.09% to -$1.1 million in 2024.
- The last three Amortization of Deferred Charges figures came in at -$1.1 million (Q4 2024), $301000.0 (Q3 2024), and $799000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | 301,000.00 |
| Sep 30, 2024 | 301,000.00 |
| Jun 30, 2024 | 799,000.00 |
| Jun 30, 2024 | 799,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 55,000.00 |
| Dec 31, 2023 | 55,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Sep 30, 2020 | 355,000.00 |
| Sep 30, 2020 | 355,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Dec 31, 2019 | 18,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Sep 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Jun 30, 2019 | 17,000.00 |
| Mar 31, 2019 | 12,000.00 |
| Mar 31, 2019 | 12,000.00 |